Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Abridge does not list a price
Free plan
Tie
Neither has one
Higher rating
Abridge
4.5 against 4.1
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Abridge
AISAP
Our rating
4.5Better
4.1
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
Ambient listening that turns patient-clinician conversations into structured notes
Deployed at Mayo Clinic, Duke Health, Johns Hopkins, and 300+ health systems
#1 Best in KLAS for Ambient AI in Revenue Cycle Management, two years running
Expanding beyond documentation into billing and clinical decision support
Roughly $830M raised, $5.3B valuation as of its Series E extension
Real-time AI interpretation of cardiac ultrasound images at the bedside
FDA clearance in the CADx pathway for structural heart disease diagnosis via POCUS
Structured, auto-generated reporting that cuts documentation time
Works with existing ultrasound hardware rather than a proprietary probe
Integrates with PACS and EMR systems already in place
Pros
Exceptional enterprise validation at some of the most prominent health systems
Strong, sustained KLAS recognition specifically for ambient AI quality
Expanding scope beyond documentation adds value without switching platforms
FDA clearance gives it regulatory standing competitors without clearance lack
Hardware-agnostic approach avoids locking hospitals into new ultrasound equipment
Backed by practicing cardiologists as co-founders, not only engineers
Cons
Enterprise pricing requires a sales conversation, no published self-serve rate
Built for large health system deployments, less suited to a solo practitioner
Broadening scope into billing and trial screening adds platform complexity to evaluate
Pricing is entirely custom and undisclosed, making budget comparison hard upfront
Aimed at institutions rather than individual clinicians shopping for a personal tool
Regulatory clearance is specific to cardiac and structural heart disease, not general ultrasound reading
Company
Abridge, founded 2018
AISAP, founded 2021
Prices come from each vendor's pricing page, last checked 20260730. Check the vendor before you buy.
FAQ
Questions people ask
Is Abridge better than AISAP?
In our reviews Abridge scores 4.5 and AISAP scores 4.1. The better pick depends on the job. Abridge: Deployed at 300+ health systems, now backed by a strategic investment from Eli Lilly. AISAP: An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time.
Abridge
AISAP
